Cary Street Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Cary Street Partners's CL Position: Q2 2026 in Review
Cary Street Partners reduced its Colgate-Palmolive (CL) stake by 0.18% in Q2 2026, selling an estimated $2.71K and leaving 17,171 shares worth $1.57M. The position accounts for 0.03% of the portfolio, ranked #408.
Cary Street Partners first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.69M in Q1 2025. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Cary Street Partners held 17,171 shares of Colgate-Palmolive worth $1.57M as of Q2 2026.
- Cary Street Partners sold 31 Colgate-Palmolive shares in Q2 2026, an estimated $2.71K.
- Colgate-Palmolive made up 0.03% of Cary Street Partners's portfolio in Q2 2026, its #408 holding.
- Cary Street Partners first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
- Cary Street Partners's Colgate-Palmolive position peaked at $1.69M in Q1 2025.
- 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.